(MedPage Today) -- By pooling all available results from trials of bone-marrow-derived stem cells (BMSCs) in patients with ischemic heart disease or congestive heart failure, a Cochrane review found slight evidence to suggest a benefit for stem-cell therapy in those populations. via MedPageToday.com - medical news plus CME for physicians Read More Here..
Lake forest health and fitness http://ift.tt/1ryAe0O
No comments:
Post a Comment